NCT00489918View on ClinicalTrials.gov

Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis

PHASE2CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

August 31, 2008

Conditions
Osteoporosis
Interventions
DRUG

teriparatide

Macroflux® patch applied to the abdomen for 30 minutes daily

DRUG

teriparatide

FORTEO® injection administered subcutaneously (SC) either to the abdomen or thigh

All Listed Sponsors
lead

Zosano Pharma Corporation

INDUSTRY

NCT00489918 - Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis | Biotech Hunter | Biotech Hunter